130 related articles for article (PubMed ID: 3469171)
1. Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.
Hochster HS; Green MD; Blum RH; Wernz JC; Speyer JL; Muggia FM
Invest New Drugs; 1986; 4(3):275-8. PubMed ID: 3469171
[TBL] [Abstract][Full Text] [Related]
2. Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Wander HE; Meyer D; Schuff-Werner P; Nagel GA
Onkologie; 1986 Aug; 9(4):236-8. PubMed ID: 3531951
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Cancer Treat Rep; 1986 Jul; 70(7):911-2. PubMed ID: 3459575
[No Abstract] [Full Text] [Related]
4. A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.
Smith DB; Howell A
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):391-4. PubMed ID: 3475204
[TBL] [Abstract][Full Text] [Related]
5. 4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
Bruzzone M; Chiara S; Falcone A; Graziani G; Conte PF; Rosso R
Chemioterapia; 1987 Apr; 6(2):137-9. PubMed ID: 3474080
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
Chisesi T; Capnist G; de Dominicis E; Dini E
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):681-4. PubMed ID: 3164269
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
8. Phase II study of idarubicin in advanced endometrial carcinoma.
Hakes TB; Raymond V
Cancer Treat Rep; 1987 May; 71(5):535-6. PubMed ID: 3471330
[No Abstract] [Full Text] [Related]
9. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
Bastholt L; Dalmark M
Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
[TBL] [Abstract][Full Text] [Related]
10. Oral idarubicin in non-Hodgkin's lymphomas.
Lopez M; Di Lauro L; Papaldo P
Invest New Drugs; 1986; 4(3):263-7. PubMed ID: 3469170
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer.
Milroy R; Cummings J; Kaye SB; Banham SW
Cancer Chemother Pharmacol; 1987; 20(1):75-7. PubMed ID: 3040287
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of idarubicin in advanced cervical carcinoma.
Hakes TB; Dougherty JB; Raymond V
Am J Clin Oncol; 1986 Jun; 9(3):262-3. PubMed ID: 3460321
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
Am J Clin Oncol; 1985 Oct; 8(5):377-9. PubMed ID: 3864366
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of 4-demethoxydaunorubicin in metastatic breast neoplasms].
Lionetto R; Ardizzoni A; Repetto L; Pronzato P; Sertoli MR; Rosso R
G Ital Chemioter; 1985; 32(1):59-60. PubMed ID: 3868637
[No Abstract] [Full Text] [Related]
15. A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Stuart NS; Cullen MH; Priestman TJ; Blackledge GR; Tyrrell CJ
Cancer Chemother Pharmacol; 1988; 21(4):351-4. PubMed ID: 3163529
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of idarubicin in patients with advanced lymphoma.
Gillies H; Liang R; Rogers H; Harper P; Parapia L; Cox G; Johnson S
Cancer Chemother Pharmacol; 1988; 21(3):261-4. PubMed ID: 3162850
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses.
Kaplan S; Sessa C; Willems Y; Pacciarini MA; Tamassia V; Cavalli F
Invest New Drugs; 1984; 2(3):281-6. PubMed ID: 6595240
[TBL] [Abstract][Full Text] [Related]
18. Preliminary observations on intravenous idarubicin (4-demethoxydaunorubicin) in the chronic and accelerated phase of chronic myelogenous leukemia.
Battista R; D'Emilio A; Vespignani M; Pacciarini MA; Dini E
Tumori; 1986 Aug; 72(4):389-93. PubMed ID: 3464125
[TBL] [Abstract][Full Text] [Related]
19. [A phase I trial of idarubicin by oral administration].
Ogawa M; Kimura K; Taguchi T; Wakui A; Hattori M; Shimoyama T; Fujita H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
Rose C; Lad TE; Kilton LJ; Schor J; Rosen ST; Rossof AH; Blough RR; Johnson CM
Invest New Drugs; 1990 Feb; 8(1):97-9. PubMed ID: 2160920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]